Trading Members of the Exchange are hereby informed that effective from May 19, 2026, the Equity Shares of Goldline Pharmaceutical Ltd (Scrip Code: 544759) are listed and admitted to dealings ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Goldline Pharmaceutical Ltd's equity shares have been listed and admitted to trading on BSE effective May 19, 2026, with scrip code 544759. This is a standard new listing announcement confirming the company has completed its IPO process and is now publicly tradable on the exchange. The filing is an administrative notice from BSE to trading members about the commencement of dealings in the scrip. No details about IPO size, pricing, or subscription status are provided in this notification.
Existing shareholders and new investors can now trade Goldline Pharmaceutical Ltd shares on BSE. This listing provides liquidity for the company's equity and allows public market participation, though the actual investment merit would need separate analysis of the IPO details.